First-line chemotherapy for non-small-cell lung cancer: Is there a superior regimen based on histology?

被引：44
|
作者：
Einhorn, Lawrence H. [1 ]
机构：
[1] Indiana Univ, Dept Med, Div Hematol Oncol, Indianapolis, IN 46204 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2008年 / 26卷 / 21期
关键词：
D O I：
10.1200/JCO.2008.17.2056
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：3485 / 3486
页数：2
相关论文
共 50 条
  • [31] Phase I/II study of paclitaxel, gemcitabine and vinorelbine as first-line chemotherapy of non-small-cell lung cancer
    Lorusso, V
    Crucitta, E
    Panza, N
    Silvestris, N
    Guida, M
    Carpagnano, F
    Mancarella, S
    Sambiasi, D
    De Lena, M
    ANNALS OF ONCOLOGY, 2002, 13 (12) : 1862 - 1867
  • [32] Does Platinum-Based Chemotherapy Still Have a Role in First-Line Treatment of Advanced Non-Small-Cell Lung Cancer?
    Lisberg, Aaron
    Garon, Edward Brian
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (07) : 529 - +
  • [33] Non-small-cell lung cancer: should histology guide chemotherapy treatment?
    Bennouna, J.
    Senellart, H.
    Douuillar, J. -Y
    ANNALS OF ONCOLOGY, 2009, 20 (09) : 1608 - 1609
  • [34] First-line cytotoxic chemotherapy regimen for non-small cell lung cancer in the elderly population: plus ca change
    Dy, Grace K.
    Khalil, Maya
    Yau, Edwin
    TRANSLATIONAL LUNG CANCER RESEARCH, 2020, 9 (04) : 1591 - 1594
  • [35] First-Line Bevacizumab-Based Therapy in Advanced Non-Squamous Non-Small-Cell Lung Cancer
    Bearz, Alessandra
    Passalacqua, Rodolfo
    Alabiso, Oscar
    Cinieri, Saverio
    Gridelli, Cesare
    Cravesana, Claudia
    Crino, Lucio
    CLINICAL DRUG INVESTIGATION, 2012, 32 (11) : 755 - 760
  • [36] First-line lorlatinib for advanced ALK-positive non-small-cell lung cancer
    Lin, Jessica J.
    Gainor, Justin F.
    LANCET RESPIRATORY MEDICINE, 2023, 11 (04): : 302 - 304
  • [37] First-line treatment of advanced ALK-positive non-small-cell lung cancer
    Gandhi, Shipra
    Chen, Hongbin
    Zhao, Yujie
    Dy, Grace K.
    LUNG CANCER-TARGETS AND THERAPY, 2015, 6 : 71 - 82
  • [38] Topotecan active as first-line combination therapy for advanced non-small-cell lung cancer
    不详
    ONCOLOGY-NEW YORK, 2001, 15 (02): : 186 - +
  • [39] Osimertinib as first-line treatment of EGFR mutant advanced non-small-cell lung cancer
    Liam, Chong-Kin
    TRANSLATIONAL LUNG CANCER RESEARCH, 2017, 6 : S62 - S66
  • [40] Pemetrexed: a new cytotoxic agent in the development for first-line non-small-cell lung cancer
    Scagliotti, GV
    LUNG CANCER, 2005, 50 : S18 - S19
12345